(Q53396459)

13 May 2018

title

Masked early symptoms of pneumonia in patients with rheumatoid arthritis during tocilizumab treatment: a report of two cases. (English)

1 reference

13 May 2018

0 references

1 reference

1 reference

Hiroshi Fujiwara

1

1 reference

13 May 2018

Norihiro Nishimoto

2

1 reference

13 May 2018

Yoshimasa Hamano

3

1 reference

13 May 2018

Nobuyuki Asanuma

4

1 reference

13 May 2018

Shunji Miki

5

1 reference

13 May 2018

Soji Kasayama

6

1 reference

13 May 2018

Masaki Suemura

7

1 reference

13 May 2018

publication date

30 August 2008

1 reference

13 May 2018

published in

Modern Rheumatology

1 reference

13 May 2018

volume

19

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

64-68

1 reference

13 May 2018

Physiology of cytokine pathways in rheumatoid arthritis

cites work

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0111-7

Interleukin-6 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0111-7

Interleukin-6: from basic science to medicine--40 years in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0111-7

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0111-7

Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0111-7

The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0111-7

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0111-7

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0111-7

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0111-7

Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-008-0111-7

10.3109/S10165-008-0111-7

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018